Wikipedia

User:Meodipt/5HT2Alist

< User:Meodipt
Code Chemical name h5-HT2A Ki / EC50 (nM) Dose (mg) PubChem CAS number Reference
AEM 1-(3,4,5-trimethoxyphenyl)butan-2-amine 204932 17097-73-3 [1]
BOH 1-(3,4-methylenedioxyphenyl)-1-methoxy-2-aminoethane 44719487 73304-06-0 PIHKAL
BOM 2-methoxy-2-(3,4,5-trimethoxyphenyl)ethanamine 98537-40-7 PIHKAL
BOD 2-(2,5-dimethoxy-4-methylphenyl)-2-methoxyethanamine 98537-41-8 PIHKAL
BOB 2-(4-bromo-2,5-dimethoxyphenyl)-2-methoxyethanamine 98537-42-9 PIHKAL
Mescaline 2-(3,4,5-trimethoxyphenyl)ethanamine 551 (vs 125I DOI) 180-360 4076 54-04-6 PIHKAL
Escaline 2-(4-ethoxy-3,5-dimethoxyphenyl)ethanamine 215 40-60 38240 39201-82-6 PIHKAL
Proscaline 2-(3,5-dimethoxy-4-propoxyphenyl)ethanamine 30-60 39201-78-0 PIHKAL
Alscaline 2-(4-allyloxy-3,5-dimethoxyphenyl)ethanamine 20-35 39201-75-7 PIHKAL
Isoproscaline 2-(4-isopropoxy-3,5-dimethoxyphenyl)ethanamine 465 40-80 64778-72-9 PIHKAL
Buscaline 2-(3,5-dimethoxy-4-butoxyphenyl)ethanamine 150+ 64778-75-2 PIHKAL
Methallylescaline 2-(3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl)ethanamine 40-65 207740-41-8 PIHKAL
Metaescaline 2-(3-ethoxy-4,5-dimethoxyphenyl)ethanamine 90132-31-3 PIHKAL
Lophophine 2-(3-methoxy-4,5-methylenedioxyphenyl)ethanamine 90239 23693-38-1 PIHKAL
Macromerine 1-(3,4-dimethoxyphenyl)-2-(dimethylamino)ethanol 165055 2970-95-8
Difluoromescaline 2-[4-(difluoromethoxy)-3,5-dimethoxyphenyl]ethanamine 50-100 1178367-63-9 [2]
Difluoroescaline 1-[4-(2,2-difluoroethoxy)-3,5-dimethoxyphenyl]-2-aminoethane 40-80 501700-02-3 Phenethylamine Von der Struktur zur Funktion
Trifluoroescaline 1-[4-(2,2,2-trifluoroethoxy)-3,5-dimethoxyphenyl]-2-aminoethane 35-65 501700-03-4 Phenethylamine Von der Struktur zur Funktion
Fluoroproscaline 1-[4-(3-fluoropropoxy)-3,5-dimethoxyphenyl]-2-aminoethane 60-150 501700-04-5 Phenethylamine Von der Struktur zur Funktion
Jimscaline (R)-(2,3-dihydro-4,5,6-trimethoxy-1H-inden-1-yl)aminomethane 69 (rat) / 3200 11673493 890309-57-6 [3]
Juncosamine (2S,6S)-2-(2,5-dimethoxy-4-bromobenzyl)-6-(2-methoxyphenyl)piperidine 1391499-52-7 [4]
3TM 2-(3-methylthio-4,5-dimethoxyphenyl)ethanamine 60-100 PIHKAL
4TM 2-(3,5-dimethoxy-4-methylthiophenyl)ethanamine 20-40 71539-35-0 PIHKAL
3TE 2-(3-methylthio-4-ethoxy-5-methoxyphenyl)ethanamine 60-80 PIHKAL
4TE 2-(3,5-dimethoxy-4-ethylthiophenyl)ethanamine 20-30 90109-49-2 PIHKAL
4TP 2-(3,5-dimethoxy-4-propylthiophenyl)ethanamine 20-25 90109-55-0 PIHKAL
4TB 2-(4-butylthio-3,5-dimethoxyphenyl)ethanamine 60-120 90109-57-2 PIHKAL
2,5-DMA 2,5-dimethoxyamphetamine 2801-68-5
3,4-DMA 3,4-dimethoxyamphetamine 120-26-3
2,4-DMA 2,4-dimethoxyamphetamine 23690-13-3
3,5-DMA 3,5-dimethoxyamphetamine 15402-82-1
2,6-DMA 2,6-dimethoxyamphetamine 23690-14-4
4-EtO-2,5-DMA 4-ethoxy-2,5-dimethoxyamphetamine 16128-88-4
2-EtO-4,5-DMA 2-ethoxy-4,5-dimethoxyamphetamine 23693-30-3
5-EtO-2,4-DMA 5-ethoxy-2,4-dimethoxyamphetamine 23693-32-5
2,4-diEtO-5-MeO-amphetamine 2,4-diethoxy-5-methoxyamphetamine 23693-33-6
2,5-diEtO-4-MeO-amphetamine 2,5-diethoxy-4-methoxyamphetamine 23693-34-7
2-MeO-4,5-diEtO-amphetamine 2-methoxy-4,5-diethoxyamphetamine 23693-35-8
2,4,5-triEtO-amphetamine 2,4,5-triethoxyamphetamine 23693-42-7
2,3,4-TMA 2,3,4-trimethoxyamphetamine 1082-23-1
2,4,5-TMA 2,4,5-trimethoxyamphetamine 1083-09-6
3,4,5-TMA 3,4,5-trimethoxyamphetamine 1082-88-8
2,4,6-TMA 2,4,6-trimethoxyamphetamine 15402-79-6
2,3,5-TMA 2,3,5-trimethoxyamphetamine 23693-14-3
2,3,6-TMA 2,3,6-trimethoxyamphetamine 20513-16-0
1-(5,8-dimethoxy-3,4-dihydro-1H-isochromen-7-yl)isopropanamine 774538-38-4
AOMA 3-methoxy-4-allyloxyamphetamine 1178502-18-5
BOMA 3-methoxy-4-benzyloxyamphetamine 114963-05-2
POMA 3-methoxy-4-propoxyamphetamine 910407-76-0
DOM 2,5-dimethoxy-4-methylamphetamine 15588-95-1
Ψ-DOM 2,6-dimethoxy-4-methylamphetamine 80888-36-4
DOET 2,5-dimethoxy-4-ethylamphetamine 22004-32-6
DOEF 2,5-dimethoxy-4-(2-fluoroethyl)amphetamine 121649-01-2
DOPR 2,5-dimethoxy-4-propylamphetamine 63779-88-4
DOBU 2,5-dimethoxy-4-butylamphetamine 63779-89-5
DOF 2,5-dimethoxy-4-fluoroamphetamine 125903-69-7
DOC 2,5-dimethoxy-4-chloroamphetamine 123431-31-2
DOB 2,5-dimethoxy-4-bromoamphetamine 32156-26-6 or 64638-07-9
N-Me-DOB N-methyl-2,5-dimethoxy-4-bromoamphetamine 155638-80-5
4C-DOB 1-(2,5-dimethoxy-4-bromophenyl)butan-2-amine 69294-23-1
4C-DOM 1-(2,5-dimethoxy-4-methylphenyl)butan-2-amine 52663-86-2 or 52842-59-8 or 52842-58-7
4C-DOC 1-(2,5-dimethoxy-4-chlorophenyl)butan-2-amine 791010-74-7
4C-DOI 1-(2,5-dimethoxy-4-iodophenyl)butan-2-amine 758631-75-3
4C-DON 1-(2,5-dimethoxy-4-nitrophenyl)butan-2-amine 775234-58-7
4-Br-3,5-DMA 3,5-dimethoxy-4-bromoamphetamine 32156-34-6 or 64778-79-6 (R)
4-PP-3,5-DMA 3,5-dimethoxy-4-(3-phenylpropyl)amphetamine 785765-10-8 [5]
DOI 2,5-dimethoxy-4-iodoamphetamine 64584-34-5 or 82830-44-2 or 82830-53-3
DON 2,5-dimethoxy-4-nitroamphetamine 67460-68-8
DOTFM 2,5-dimethoxy-4-(trifluoromethyl)amphetamine 159277-07-3
DOYN 2,5-dimethoxy-4-ethynylamphetamine 633290-70-7
DODC 2,5-dimethoxy-3,4-dichloroamphetamine 1373918-65-0
DOBn 2,5-dimethoxy-4-benzylamphetamine 125903-73-3
DOTh 2,5-dimethoxy-4-[(thiophen-2-yl)methyl]amphetamine 930776-29-7
DO(3-MeOBn) 2,5-dimethoxy-4-(3-methoxybenzyl)amphetamine 930836-90-1
DOMOM 2,5-dimethoxy-4-(methoxymethyl)amphetamine 260810-10-4
DOMOE 2,5-dimethoxy-4-(ethoxymethyl)amphetamine 930836-81-0
DOTHFM 2,5-dimethoxy-4-[(tetrahydrofuran-2-yl)methyl]amphetamine 930776-12-8
ALEPH 2,5-dimethoxy-4-(methylthio)amphetamine 61638-07-1
ALEPH-2 2,5-dimethoxy-4-(ethylthio)amphetamine 185562-00-9
ALEPH-4 2,5-dimethoxy-4-(isopropylthio)amphetamine 123643-26-5
ALEPH-7 2,5-dimethoxy-4-(propylthio)amphetamine 207740-16-7
TOM-2 2-methylthio-4-methyl-5-methoxyamphetamine 60-100 207740-44-1
TOM-5 2-methoxy-4-methyl-5-methylthioamphetamine 30-50 207740-45-2
TOET-2 2-methylthio-4-ethyl-5-methoxyamphetamine 84910-91-8
TOET-5 2-methoxy-4-ethyl-5-methylthioamphetamine 12-25 207740-43-0
TOMSO 2-methoxy-4-methyl-5-methylsulfinylamphetamine 100-150 84910-95-2
2C-B 2,5-dimethoxy-4-bromophenethylamine 66142-81-2 PIHKAL
β-Methyl-2CB 2-(2,5-dimethoxy-4-bromophenyl)-1-aminopropane 52432-70-9 Phenethylamine Von der Struktur zur Funktion

References edit

  1. ^ Alexander Shulgin, Ann Shulgin. PiHKAL: A Chemical Love Story. Transform Press 1991. ISBN 0963009605
  2. ^ Daniel Trachsel, David Lehmann and Christoph Enzensperger. Phenethylamine Von der Struktur zur Funktion. Nachtschatten Verlag AG, 2013. ISBN 9783037887004
  3. ^ Michael Robert Braden PhD. Towards a biophysical understanding of hallucinogen action. Purdue University 2007
  4. ^ Juncosa JI, Hansen M, et al. Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands. ACS Chemical Neuroscience 2012. 4: 120717095020003. doi:10.1021/cn3000668
  5. ^ Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT2A Partial Agonists. J Med Chem. 2000 Aug 10;43(16):3074-84. PMID 10956215

Miscellaneous 5HT2A agonists edit

Structure Name Chemical name h5-HT2A Ki (EC50) (nM) PubChem CAS number Reference
  Compound 23 9-Chloro-7-(2-ethoxy-phenyl)-2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole 32 44315398 599173-25-8 [1]
  Compound 10d 7-Benzyloxy-8-bromo-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine 22 10472780 616201-60-6 [2]
  Example 22.67 4-(6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepin-2-yl)thiomorpholine 21 44124494 [3]
  Compound 3d (N-Bn-THAZ) 2-benzyl-5,6,7,8-tetrahydro-4H-[1,2]oxazolo[4,5-d]azepin-3-one (549) 14515725 125115-66-4 [4]
  Example 1 (ZC-B) 3-(4-bromo-2,5-dimethoxyphenyl)azetidine (1.6) 156337249 2641630-65-9 [5]
  Compound 11 (3R)-N,N-diethyl-5-(1H-indol-4-yl)-1-methyl-3,6-dihydro-2H-pyridine-3-carboxamide (<10) 156278040 [6]
  Compound 106 6-chloro-1-(2,4,5-trimethoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole 4376990 528525-37-3 [7]
  Compound 6c (6S)-2,3-dichloro-7,8,9,10-tetrahydro-6H-6,9-epiminocyclohepta[b]quinoxaline (400) [8]
  Efavirenz (4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one 64139 154598-52-4 [9]
  IHCH-7113 (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline 21302499 313368-85-3 [10]
  Mefloquine 2,8-bis(trifluoromethyl)quinolin-4-yl-(2-piperidyl)methanol 40692 53230-10-7 [11]
  ORG-37684 (3S)-3-[(2,3-dihydro-5-methoxy-1H-inden-4-yl)oxy]pyrrolidine 9794656 213007-95-5 [12]
  P-54 2-(5-methoxypyrazolo[1,5-a]pyridin-3-yl)-N,N-dimethylethanamine 168946740 [13]
  (R)-69 3-[(5R)-5-methyl-1,2,5,6-tetrahydropyridin-3-yl]-1H-pyrrolo[2,3-b]pyridine 164513426 [14]
  RH-34 3-[2-(2-methoxybenzylamino)ethyl]-1H-quinazoline-2,4-dione 10041987 1028307-48-3 [15]
  SCHEMBL5334361 7-[(3-methoxyphenoxy)methyl]-2,3,4,5-tetrahydro-1H-3-benzazepine (0.4) 59027940 959867-47-1 [16]
  WXVL_BT0793LQ2118 6-fluoro-4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1H-indole [17]
  Z2825713589 (4-amino-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-(6-methoxypyrazin-2-yl)methanone 167788805 [17]
  Z2876442907 ethyl 2-[[2-(4-methyl-1H-indol-3-yl)ethylamino]methyl]-1,3-thiazole-5-carboxylate 167850865 [17]
  Z3517967757 4-[1-(1-pyrimidin-2-ylethyl)piperidin-3-yl]phenol 167949972 [17]
  Z3881312504 2-bromo-4-[2-[methyl-[2-(1,3-thiazol-2-yl)ethyl]amino]ethyl]phenol 167904469 [17]
  Z4154032166 2,2,2-trifluoro-1-[6-(1,2,3,6-tetrahydropyridin-5-yl)pyridin-2-yl]ethanol 167878716 [17]
  Z5247692566 4-[(3,3-dimethyloxolan-2-yl)methyl]-3-[(1H-indol-3-yl)methyl]morpholine [17]
  Z5247692629 1-(1-bicyclo[1.1.1]pentanyl)-4-[[5-(4-chlorophenyl)-1H-pyrazol-4-yl]methyl]piperazine 166358273 [17]
  1. ^ Ennis MD, Hoffman RL, Ghazal NB, Olson RM, Knauer CS, Chio CL, Hyslop DK, Campbell JE, Fitzgerald LW, Nichols NF, Svensson KA, McCall RB, Haber CL, Kagey ML, Dinh DM. 2,3,4,5-tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT(2C) agonists. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2369-72. doi:10.1016/s0960-894x(03)00403-7 pmid|12824036}}
  2. ^ Smith BM, Smith JM, Tsai JH, Schultz JA, Gilson CA, Estrada SA, Chen RR, Park DM, Prieto EB, Gallardo CS, Sengupta D, Thomsen WJ, Saldana HR, Whelan KT, Menzaghi F, Webb RR, Beeley NR. Discovery and SAR of new benzazepines as potent and selective 5-HT(2C) receptor agonists for the treatment of obesity. Bioorg Med Chem Lett. 2005 Mar 1;15(5):1467-70. doi:10.1016/j.bmcl.2004.12.080 PMID 15713408
  3. ^ Slassi A, et al. Compounds with activity at the 5-ht2c receptor. WO 2009/079765
  4. ^ Jensen AA, Plath N, Pedersen MH, Isberg V, Krall J, Wellendorph P, Stensbøl TB, Gloriam DE, Krogsgaard-Larsen P, Frølund B. Design, synthesis, and pharmacological characterization of N- and O-substituted 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol analogues: novel 5-HT(2A)/5-HT(2C) receptor agonists with pro-cognitive properties. J Med Chem. 2013 Feb 14;56(3):1211-27. doi:10.1021/jm301656h PMID 23301527
  5. ^ US 2021/0137908, Kristensen JL, Jensen AA, Märcher-Rørsted E, "5-HT2A Agonists for Use in Treatment of Depression.", published 13 May 2021, assigned to Lophora ApS. 
  6. ^ WO 2021/076572, Olson DE, et al., "Ergoline-like compounds for promoting neural plasticity" 
  7. ^ Orr MJ, et al. Discovery of Highly Potent Serotonin 5-HT2 Receptor Agonists Inspired by Heteroyohimbine Natural Products. ACS Med. Chem. Lett. 2022; 13(4):648–657. doi:10.1021/acsmedchemlett.1c00694
  8. ^ Yao R, Jensen AA, Bryce-Rogers HP, Schultz-Knudsen K, Zhou L, Hovendal NP, et al. (August 2023). "Identification of 5-HT2 Serotonin Receptor Modulators through the Synthesis of a Diverse, Tropane- and Quinuclidine-alkaloid-Inspired Compound Library". Journal of Medicinal Chemistry. 66 (16): 11536–11554. doi:10.1021/acs.jmedchem.3c01059. PMID 37566000. S2CID 260806387.
  9. ^ Gatch MB, Kozlenkov A, Huang RQ, Yang W, Nguyen JD, González-Maeso J, Rice KC, France CP, Dillon GH, Forster MJ, Schetz JA. The HIV antiretroviral drug efavirenz has LSD-like properties. Neuropsychopharmacology. 2013 Nov;38(12):2373-84. doi:10.1038/npp.2013.135 PMID 23702798
  10. ^ Cao D, Yu J, Wang H, Luo Z, Liu X, He L, et al. (January 2022). "Structure-based discovery of nonhallucinogenic psychedelic analogs". Science. 375 (6579): 403–411. doi:10.1126/science.abl8615. PMID 35084960. S2CID 246360313.
  11. ^ Janowsky A, Eshleman AJ, Johnson RA, Wolfrum KM, Hinrichs DJ, Yang J, Zabriskie TM, Smilkstein MJ, Riscoe MK. Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro. Psychopharmacology (Berl). 2014 Jul;231(14):2771-83. doi:10.1007/s00213-014-3446-0 PMID 24488404
  12. ^ Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M (August 2004). "Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors". Naunyn-Schmiedeberg's Archives of Pharmacology. 370 (2): 114–23. doi:10.1007/s00210-004-0951-4. PMID 15322733. S2CID 8938111.
  13. ^ WO 2023115165, Banister S, Jorgensen W, Jinlong T, "Compounds", published 29 June 2023, assigned to Psylo Pty Ltd. 
  14. ^ Kaplan AL, Confair DN, Kim K, Barros-Álvarez X, Rodriguiz RM, Yang Y, et al. (September 2022). "Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity". Nature. 610 (7932): 582–591. Bibcode:2022Natur.610..582K. doi:10.1038/s41586-022-05258-z. PMC 9996387. PMID 36171289. S2CID 252598838.
  15. ^ Silva ME, Heim R, Strasser A, Elz S, Dove S (January 2011). "Theoretical studies on the interaction of partial agonists with the 5-HT(2A) receptor". Journal of Computer-aided Molecular Design. 25 (1): 51–66. Bibcode:2011JCAMD..25...51S. CiteSeerX 10.1.1.688.2670. doi:10.1007/s10822-010-9400-2. PMID 21088982. S2CID 3103050.
  16. ^ WO 2007149728, Mohapatra S, Hellberg MR, Feng Z, "Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma", assigned to Alcon Manufacturing, Ltd. 
  17. ^ a b c d e f g h Lyu J, Kapolka N, Gumpper R, Alon A, Wang L, Jain MK, et al. (December 2023). "AlphaFold2 structures template ligand discovery". bioRxiv. doi:10.1101/2023.12.20.572662. PMC 10769324. PMID 38187536.
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Meodipt/5HT2Alist&oldid=1197394190"